CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

UBS Initiates Coverage on Integra LifeSciences With Neutral Rating, $19 Price Target

Neutral
AI Analysis

Summary

UBS initiated coverage on Integra LifeSciences with a Neutral rating and $19 price target.

Importance:2/10
Sentiment:
0.00
analyst_coverageratingprice_target
Related Companies

Read the original article

Published by yahoo_finance on July 28, 2026 2:40 PM

Read Original